ALEXANDRIA, Va. — Conquer Cancer^®, the ASCO Foundation, is proud to announce the recipients of its 2026 Breakthrough Merit and Abstract Awards.  

These awards recognize students, trainees, and junior faculty for their valuable research in clinical cancer treatment and technology innovations in cancer care. Awardees will present their research in Singapore, June 25-27, 2026, during ASCO Breakthrough, a yearly oncology meeting bringing together thought leaders, clinicians, technology pioneers, novel drug developers and researchers for inspiration, collaboration, and more. 

Abstract Awards support the first authors of the 40 highest-rated abstracts selected for presentation during ASCO Breakthrough. The awards are generously supported by Novocure.  

Merit Awards recognize the quality and scientific merit of research submitted by students and trainees to an ASCO meeting. 

See the complete list of 2026 Breakthrough Merit and Abstract Award recipients. 

Supporters: 

The 2026 Conquer Cancer^® Merit Awards are generously supported by Terri Armstrong, Chris Armstrong, and Mark Gilbert; ASCO Employees; Association of Northern California Oncologists; AstraZeneca; Friends and Family of Dr. and Mrs. Ronald Beller; Dr. and Mrs. Douglas W. Blayney; Breast Cancer Research Foundation^®; Bristol Myers Squibb; Vince D. Cataldo, MD; Jonathan K. and Cora Y. Cho Charitable Fund; Friends, Family, and Colleagues of Dr. Cecil "Pete" Coggins; Michael Craig Cox, PharmD, MHS, BCOP; Trailblazing patient Mark A. Crafts and Generous Supporters of Team Crafty; Gina D'Amato, MD; Bill and Karen Dahut; Allison Dray; Eisai Inc.; Estate of Darla C. Ellis; Epiphany Partners, Inc.; Flatiron Health, Inc.; GSK; Harborside; Friends, Colleagues, and Family of Joe Hogan; John Hohneker, MD and Donald Vincent; Melissa M. Hudson, MD, FASCO and Albert E. Weeks, MD; Kimberly Irvine; Drs. Kevin Kalinsky and Christopher Keir; Family of Diane L. Keith; Drs. Karen Knudsen and Brian Costello; Nicole M. Kuderer, MD and Gary H. Lyman, MD, MPH, FASCO; Natasha B. Leighl, MD, FASCO; William T. Leslie, MD; Lilly; Bora Lim, MD and Pavlos Msaouel, MD, PhD; Loxo Oncology Inc., a wholly owned subsidiary of Eli Lilly and Company; Maryland/District of Columbia Society of Clinical Oncology; Friends and Colleagues of Theresa Mays; Melanoma Research Foundation; Estate of Mike Miller; Therese Marie Mulvey, MD, FASCO; Friends and Family of Dr. James B. Nachman; New Rhein Healthcare, LLC; Friends and Colleagues of Dr. Larry Norton; Dr. Kurt R. Oettel; Dr. Kathleen Pritchard Medicine Professional Corporation; The QuadW Foundation; Gabrielle Betty Rocque, MD, MSPH; Sarah Cannon Research Institute; Frances A. Shepherd, MD, FASCO; Stephen A. Sherwin, MD; Drs. Rachna and Puneet Shroff; Dr. Walter and Mrs. Lisa Stadler; ASCO’s State Affiliate Council; Stemline, Inc, a Menarini Group Company; Supporters of Innovations and Research in Medical Education; Syndax Pharmaceuticals, Inc.; Nizar M. Tannir, MD; Anthony and Marilyn Tolcher; Dr. Michael and Deborah Troner; and William S. Yaus, Jeffrey W. Yaus, and Kathleen Y. Wolin, ScD.  

The 2026 ASCO Breakthrough Abstract Awards are generously supported by Novocure.  

This listing is current as of May 8, 2026.